Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium
- PMID: 38459218
- PMCID: PMC10923734
- DOI: 10.1007/s40520-023-02679-2
Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium
Abstract
Recent medical advancements have increased life expectancy, leading to a surge in patients affected by multiple chronic diseases and consequent polypharmacy, especially among older adults. This scenario increases the risk of drug interactions and adverse drug reactions, highlighting the need for medication review and deprescribing to reduce inappropriate medications and optimize therapeutic regimens, with the ultimate goal to improving patients' health and quality of life. This position statement from the Italian Scientific Consortium on medication review and deprescribing aims to describe key elements, strategies, tools, timing, and healthcare professionals to be involved, for the implementation of medication review and deprescribing in different healthcare settings (i.e., primary care, hospital, long-term care facilities, and palliative care). Challenges and potential solutions for the implementation of medication review and deprescribing are also discussed.
Keywords: Deprescribing; Frailty; Medication review; Multimorbidity; Patient-centered care; Polypharmacy.
© 2024. The Author(s).
Conflict of interest statement
GT has served in the last 3 years on advisory boards/seminars funded by Sanofi, Eli Lilly, AstraZeneca, Abbvie, Novo Nordisk, Gilead, and Amgen; he is also a scientific coordinator of the academic spin-off “INSPIRE srl”, which has received funding for conducting observational studies from several pharmaceutical companies. None of these listed activities is related to the topic of the article. The other authors have no competing interests to declare that are relevant to the content of this article.
Figures
References
-
- Osservatorio Nazionale sull’Impiego dei Medicinali (OsMed). L’uso dei farmaci in Italia. Agenzia Italiana del Farmaco. https://www.aifa.gov.it/rapporti-osmed. Accessed 14 Nov 2023
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources